Infectious Disease Diagnostics
Tulane was founded as a university centered around public health and infectious diseases. Various labs throughout the School of Medicine have continued this tradition by creating novel diagnostics in the global health space, including a tuberculosis point-of-care test and a multiplex Lyme disease test. The university has also pioneered several CRISPR diagnostics ranging from SARS-CoV-2 to Cytomegalovirus to Borrelia and more.
Publications
Evaluation of a serum-based antigen test for tuberculosis in HIV-exposed infants: a diagnostic accuracy study
View
CRISPR detection of circulating cell-free Mycobacterium tuberculosis DNA in adults and children, including children with HIV: a molecular diagnostics study
View
Diagnosis of paediatric tuberculosis by optically detecting two virulence factors on extracellular vesicles in blood samples
View
Serum-based Diagnosis of Pediatric Tuberculosis by Assay of Mycobacterium tuberculosis Factors: a retrospective cohort study
View
Evaluation of SARS-CoV-2-Specific T-Cell Activation with a Rapid On-Chip IGRA
View
Liposome-mediated detection of SARS-CoV-2 RNA-positive extracellular vesicles in plasma
View
Rapid detection of multiple SARS-CoV-2 variants of concern by PAM-targeting mutations
View
Ultra-sensitive and high-throughput CRISPR-powered COVID-19 diagnosis
View
Borrelia burgdorferi Migration Assays for Evaluation of Chemoattractants in Tick Saliva
View
Engage with Us
Flexible collaboration models available — Sponsored Research, Co-Development, Licensing.
For inquiries, contact:
Elaine Hamm, PhD
Executive in Residence
Email me